• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
ProAxsis CEO to present at Anglonordic Conference
Share
Conferences, News

ProAxsis CEO to present at Anglonordic Conference

May 30, 2017
-
Posted by Webmaster

Dr David Ribeiro, CEO of ProAxsis, will be attending the Anglonordic Life Sciences Conference, taking place in London this week, and will be presenting a company update as part of the Biotech Investment Programme at 2pm on May 31st. This will be the 14th annual meeting of this partnering conference.

Dr Ribeiro said: “This is the first time that we’ll have participated in this event, so I’m very much looking forward to engaging with the attendees from the investor and biotech communities. Our point-of-care test for monitoring active neutrophil elastase in diseases such as COPD and cystic fibrosis is in its final stages of development, so this is an excellent time for us to be meeting prospective partners for this exciting technology.”

Any requests from either pharmaceutical companies or academic researchers for support to measure active proteases or other inflammatory biomarkers can be directed to info@proaxsis.com.

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.

May 30, 2017
No comments yet

Related News

Other posts that you should not miss.
News

ProAxsis Ltd CEO Update Report – End Q4 2021

January 7, 2022
-
Posted by Jessica Robinson

Introduction As 2022 commences, I am pleased to provide an update on the progress made with regard …

Read More
January 7, 2022
Posted by Jessica Robinson
News, ProteaseTag®

ProAxsis abstracts at 2017 European Respiratory Society Conference

September 6, 2017
-
Posted by Webmaster

ProAxsis will be presenting further data on its ProteaseTag® technology, at the European Respiratory Society Conference, which takes …

Read More
September 6, 2017
Posted by Webmaster
News

ProAxsis Ltd CEO Update Report – May 2021

May 21, 2021
-
Posted by Webmaster

Introduction In parallel with the release of the company’s 2020 financial statements, I am pleased to provide …

Read More
May 21, 2021
Posted by Webmaster
← PREVIOUS POST
ProAxsis’ Active Neutrophil Elastase Immunoassay highlighted in Stanford University trial
NEXT POST →
ProAxsis technology highlighted in AJRCCM editorial

Leave a Comment

Your feedback is valuable for us. Your email will not be published.
Cancel Reply

Please wait...
Submit Comment

Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
    June 7, 2021

    ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it …

  • ProAxsis Ltd CEO Update Report – May 2021
    May 21, 2021

    Introduction In parallel with the release of the company’s 2020 financial statements, I …

  • ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
    February 21, 2021

    ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • July 26, 2022
    ProAxsis announces additional key appointments
  • May 17, 2022
    Belfast Telegraph Awards
  • May 16, 2022
    ProAxsis announces “impressive” results in Performance Evaluation of COVID-19 antibody test
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis CEO to present at Anglonordic Conference - ProAxsis